{"id":"migliol-placebo-oil","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Migliol (also known as Miglyol) is a pharmaceutical-grade medium-chain triglyceride (MCT) oil composed primarily of capric and caprylic acids. It is pharmacologically inert and is commonly used as a placebo comparator or vehicle in clinical studies rather than as an active therapeutic agent. In Phase 3 trials, it serves as a control to assess the efficacy of investigational drugs.","oneSentence":"Migliol is a medium-chain triglyceride oil used as a placebo or inert control vehicle in clinical trials.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:50:03.006Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Placebo control in clinical trials"}]},"trialDetails":[{"nctId":"NCT00493012","phase":"NA","title":"Vitamin D Effects in Overweight Patients","status":"COMPLETED","sponsor":"Heart and Diabetes Center North-Rhine Westfalia","startDate":"2006-01","conditions":"Overweight, Obesity","enrollment":200},{"nctId":"NCT01326650","phase":"PHASE4","title":"Vitamin D and Mortality in Heart Failure","status":"COMPLETED","sponsor":"Heart and Diabetes Center North-Rhine Westfalia","startDate":"2010-11","conditions":"Congestive Heart Failure","enrollment":400},{"nctId":"NCT02507843","phase":"PHASE4","title":"Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis","status":"UNKNOWN","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2015-01","conditions":"Bronchiectasis","enrollment":200},{"nctId":"NCT00672763","phase":"PHASE4","title":"Adjuvant Vitamin D With Corticosteroids in Active Crohn's Disease","status":"WITHDRAWN","sponsor":"Imperial College London","startDate":"2008-05","conditions":"Crohn's Disease","enrollment":""},{"nctId":"NCT00366470","phase":"PHASE3","title":"A Clinical Trial to Study the Effect of the Addition of Vitamin D to Conventional Treatment in New Pulmonary Tuberculosis Patients","status":"COMPLETED","sponsor":"Peter Daley","startDate":"2009-11","conditions":"Pulmonary Tuberculosis","enrollment":250},{"nctId":"NCT00419068","phase":"PHASE3","title":"Trial of Adjunctive Vitamin D in Tuberculosis Treatment","status":"COMPLETED","sponsor":"Barts & The London NHS Trust","startDate":"2007-01","conditions":"Tuberculosis, Pulmonary","enrollment":146}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Migliol Placebo Oil","genericName":"Migliol Placebo Oil","companyName":"Barts & The London NHS Trust","companyId":"barts-the-london-nhs-trust","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Migliol is a medium-chain triglyceride oil used as a placebo or inert control vehicle in clinical trials. Used for Placebo control in clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}